E-DRUG: Prescrire Independent Drug & Healthcare Newsletter for Sept 2015
----------------------------------------------------------------------------
Newsletter, September 2015 - Online version N° 163 September 2015
View the table of contents for the current issue
http://english.prescrire.org/en/SummaryDetail.aspx?Issueid=163
Drug-induced lesions of the oesophageal mucosa
FEATURED REVIEW Drugs provoke oesophageal lesions through a variety of mechanisms. Which drugs expose patients to the risk of oesophageal mucosal lesions?
Full review (4 pages) available for download by subscribers.
Read more
http://english.prescrire.org/en/81/168/50065/0/NewsDetails.aspx
In the September issue of Prescrire International:
Aflibercept (Eylea°) and diabetic macular oedem
FREE DOWNLOAD Aflibercept (Eylea°), a VEGF inhibitor, is authorised for intravitreal administration in the treatment of diabetic macular oedema. How does it compare to other VEGF inhibitors in this setting?
Full text available for free download.
Read more
http://english.prescrire.org/en/81/168/50066/0/NewsDetails.aspx
Age-related macular degeneration: do not take risks in order to cut costs
In the best interests of patients suffering from age-related macular degeneration (AMD), it is better to prescribe ranibizumab, despite its inflated price, which must be challenged and reduced, as opposed to bevacizumab.
Read more
http://english.prescrire.org/en/81/168/50067/0/NewsDetails.aspx
Type 2 diabetes: Mediterranean diet helps delay drug treatment
A trial has shown that if patients suffering from recently discovered type 2 diabetes switch to a Mediterranean diet, this appears to delay the need for treatment with glucose lowering drugs as opposed to a low-fat diet.
Read more
http://english.prescrire.org/en/81/168/50069/0/NewsDetails.aspx
Drugs sold cheaply to hospitals push up prices in pharmacies
Hospital prescriptions have a major impact on prescriptions in the community. Pharmaceutical companies sell some drugs cheaply to hospitals in order to increase sales in pharmacies.
Read more
http://english.prescrire.org/en/81/168/50068/0/NewsDetails.aspx
French non-profit medical journal Prescrire devotes its special summer edition to "Therapeutic advances that benefit patients"
Genuine therapeutic advances are few and far between, and they can be difficult to spot. The independent journal Prescrire helps to single them out.
Read more
http://english.prescrire.org/en/81/168/50021/0/NewsDetails.aspx
Prescrire International <international@prescrire.org>